Gout Drug Receives Approval
Links shared publicly online about this topic.
- 859total visits
Gout Drug Receives Approval
View full resource at hcplive.com
Tags: Crystal Disorders, Gout, Drug
Most Recently Shared on September 20, 2010 at 6:20 pm By:
Gout Drug Receives Approval http://hcp.lv/aNTuYi
Amgen Loses Monopoly on Drug for Dialysis Patients - NYTimes.com
nytimes.com — “The Food and Drug Administration approved a new anemia drug called Omontys for dialysis patients, which will end Amgen’s 24-year monopoly led by its Epogen drug.” View full resource at nytimes.com
Most Recently Shared on March 27, 2012 at 6:27 pm By:
Anas Younes, M.D. Oncologist, Physician, Doctor, and Internist
F.D.A. Approves Affymax's new drug Omontys for anemic patients receiving kidney dialysis... http://t.co/2o68syVQ
Boniva generics receive FDA approval for treatment, prevention of osteoporosis
news-medical.net — “The U.S. Food and Drug Administration today approved the first generic versions of Boniva (ibandronate) tablets, a once-monthly product to treat or prevent osteoporosis in women after menopause.” View full resource at news-medical.net
Most Recently Shared on March 27, 2012 at 1:12 pm By:
Boniva generics receive FDA approval for treatment, prevention of osteoporosis: The U.S. Food and Drug Administr... http://t.co/YbYOsv15
Surfaxin receives FDA approval for prevention of RDS in premature infants
news-medical.net — “The U.S. Food and Drug Administration today approved Surfaxin (lucinactant) for the prevention of respiratory distress syndrome (RDS), a breathing disorder that affects premature infants.” View full resource at news-medical.net
Most Recently Shared on March 27, 2012 at 1:12 pm By:
Surfaxin receives FDA approval for prevention of RDS in premature infants: The U.S. Food and Drug Administration... http://t.co/gUtgTOgn
Drug Dosage Was Approved Despite Warning - NYTimes.com
nytimes.com — “The Alzheimer’s drug Aricept 23 was set to lose its patent, but its makers received approval for a higher dosage that extended their exclusivity.” View full resource at nytimes.com
Most Recently Shared on March 27, 2012 at 2:04 am By:
Brad Stuart Physician, Doctor, Internist, and Pain Medicine Physician
A new low in drug marketing + lack of regulation http://t.co/9HF6cWJR
Drug Dosage Was Approved Despite Warning - NYTimes.com
nytimes.com — “The Alzheimer’s drug Aricept 23 was set to lose its patent, but its makers received approval for a higher dosage that extended their exclusivity.” View full resource at nytimes.com
Most Recently Shared on March 24, 2012 at 8:30 pm By:
Should this #Alzheimer drug's patent have been extended despite warning about troubling side effects? http://t.co/uGGdCFg2
Drug Dosage Was Approved Despite Warning - NYTimes.com
nytimes.com — “The Alzheimer’s drug Aricept 23 was set to lose its patent, but its makers received approval for a higher dosage that extended their exclusivity.” View full resource at nytimes.com
Most Recently Shared on March 24, 2012 at 3:58 am By:
Drug Dosage Was Approved Despite Warning: http://t.co/gLW3RU6E
Drug Dosage Was Approved Despite Warning - NYTimes.com
nytimes.com — “The Alzheimer’s drug Aricept 23 was set to lose its patent, but its makers received approval for a higher dosage that extended their exclusivity.” View full resource at nytimes.com
Most Recently Shared on March 23, 2012 at 11:06 pm By:
Amy Berman Health Organization
Deeply disturbing piece from NYTimes: Drug Dosage Was Approved Despite Warning http://t.co/msEYrQdM
Drug Dosage Was Approved Despite Warning - NYTimes.com
nytimes.com — “The Alzheimer’s drug Aricept 23 was set to lose its patent, but its makers received approval for a higher dosage that extended their exclusivity.” View full resource at nytimes.com
Most Recently Shared on March 23, 2012 at 3:32 pm By:
George Huba, Ph.D. PhD, Doctor, and Psychologist
NYT: Drug Dosage Was Approved Despite Warning - Aricept 23 was developed by the Japanese pharmaceutical company Eisa... http://t.co/KAZJYoT9
Markey targets Boston Scientific and other vaginal mesh manufacturers in new bill - Daily Dose: A Boston Globe blog with health news, advice, and information.
boston.com — “Representative Edward Markey, a Massachusetts Democrat, introduced legislation to tighten regulations for medical devices such as vaginal mesh implants that are similar to products known to cause medical problems. It would give the Food and Drug Administration more authority over approval of new devices based on older models that have proven to be unsafe. But so far, the legislation hasn’t received support from Republicans.” View full resource at boston.com
Most Recently Shared on March 23, 2012 at 2:06 pm By:
Markey targets #vaginal #mesh manufacturers http://t.co/D5eDJwEr
Drug Dosage Was Approved Despite Warning - NYTimes.com
nytimes.com — “The Alzheimer’s drug Aricept 23 was set to lose its patent, but its makers received approval for a higher dosage that extended their exclusivity.” View full resource at nytimes.com
Most Recently Shared on March 23, 2012 at 1:57 pm By:
NYT: Drug Dosage Was Approved Despite Warning http://t.co/inId49mN
Drug Dosage Was Approved Despite Warning - NYTimes.com
nytimes.com — “The Alzheimer’s drug Aricept 23 was set to lose its patent, but its makers received approval for a higher dosage that extended their exclusivity.” View full resource at nytimes.com
Most Recently Shared on March 23, 2012 at 1:57 pm By:
NYT: Drug Dosage Was Approved Despite Warning http://t.co/inId49mN
Drug Dosage Was Approved Despite Warning - NYTimes.com
nytimes.com — “The Alzheimer’s drug Aricept 23 was set to lose its patent, but its makers received approval for a higher dosage that extended their exclusivity.” View full resource at nytimes.com
Most Recently Shared on March 23, 2012 at 1:05 pm By:
Susan Krauss Whitbourne PhD, Doctor, and Psychologist
Chilling tale about Aricept's approval for stronger dose despite high risks and lack of effectiveness. #pharma #psych http://t.co/wUEvIdMi
Drug Dosage Was Approved Despite Warning - NYTimes.com
nytimes.com — “The Alzheimer’s drug Aricept 23 was set to lose its patent, but its makers received approval for a higher dosage that extended their exclusivity.” View full resource at nytimes.com
Most Recently Shared on March 23, 2012 at 1:01 pm By:
Dr. Steven Z. Kussin Internist, Gastroenterologist, Physician, and Doctor
Two articles on your friendly BigPhama companies and Device companies. You are spending too much time worrying... http://t.co/AqRbDd1B
Drug Dosage Was Approved Despite Warning - NYTimes.com
nytimes.com — “The Alzheimer’s drug Aricept 23 was set to lose its patent, but its makers received approval for a higher dosage that extended their exclusivity.” View full resource at nytimes.com
Most Recently Shared on March 23, 2012 at 11:49 am By:
Kent Bottles, MD Physician, Doctor, and Pathologist
Drug Dosage Was Approved Despite Warning: http://t.co/3Yuby2Wo
Drug Dosage Was Approved Despite Warning - NYTimes.com
nytimes.com — “The Alzheimer’s drug Aricept 23 was set to lose its patent, but its makers received approval for a higher dosage that extended their exclusivity.” View full resource at nytimes.com
Most Recently Shared on March 23, 2012 at 11:05 am By:
Drug Dosage Was Approved Despite Warning http://t.co/Mk0uqRGH
Advertisement
